PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species ▼ | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
Protein F (Antigen I/II)
|
Fibronectin
|
Glycoproteins
|
Respiratory epithelial cells
|
Binding
|
|||
Unknown
|
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
|
Oligoglycosylceramides
|
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
CTB-PsaA pentamers
|
GM1
|
Monosialoglycosphingolipids
|
Serum, Saliva, Nasal/bronchial wash samples
|
Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Adhesins
|
N-Acetylgalactosamine
|
Monosaccharides
|
Type-II lung cells, Vascular endothelial cells
|
GalNAc
|
Binding
|
||
Adhesins
|
D-Mannose
|
Monosaccharides
|
Type-II lung cells, Vascular endothelial cells
|
Man
|
Binding
|
||
Adhesins
|
D-Galactose
|
Monosaccharides
|
Vascular endothelial cells (only)
|
Gal
|
Binding
|
||
Adhesins
|
Asialo-GM2 (Gangliotriosylceramide; GgO3)
|
Oligoglycosylceramides
|
Type-II lung cells, Vascular endothelial cells
|
GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Adhesins
|
Gb4 (Globoside; Globotetraose; P antigen)
|
Oligoglycosylceramides
|
Type-II lung cells, Vascular endothelial cells
|
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Adhesins
|
Gb5 (Forssman glycolipid)
|
Oligoglycosylceramides
|
Type-II lung cells, Vascular endothelial cells
|
GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
CBPs (choline-binding proteins)
|
nLc4Cer (Neolactotetraosylceramide; Paragloboside)
|
Oligoglycosylceramides
|
Cytokine-activated cells
|
Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01